Adaptive Biotechnologies (ADPT) Debt Ratio (2022 - 2026)

Adaptive Biotechnologies has reported Debt Ratio for 5 years, with the latest figure at 0.26 in Q1 2026.

• Quarterly Debt Ratio fell 1.3% year-over-year to 0.26 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.26 (down 1.3% YoY) and the FY2025 annual result came in at 0.26, up 3.56% from the prior year.
• Debt Ratio improved to 0.26 in Q1 2026 per ADPT's latest filing, from 0.26 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.27 in Q2 2025 and troughed at 0.15 in Q4 2022.
• A 5-year average of 0.23 and a median of 0.24 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2023 and 2026: Debt Ratio soared 35.05% in 2023, then decreased 1.3% in 2026.
• Over 5 years, Debt Ratio stood at 0.15 in 2022, then jumped by 35.05% to 0.2 in 2023, then increased by 25.03% to 0.25 in 2024, then grew by 3.56% to 0.26 in 2025, then increased by 0.84% to 0.26 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.26, 0.26, and 0.27 for Q1 2026, Q4 2025, and Q3 2025 respectively.